R. Bosch

The recovery of urinary continence after radical retropubic prostatectomy: a randomized trial comparing the effect of physiotherapist-guided pelvic floor muscle exercises with guidance by an instruction folder only.

Study Type – Therapy (RCT)
Level of Evidence 1b

Clinical superficial Raman probe aimed for epithelial tumor detection: Phantom model results

A novel clinical Raman probe for sampling superficial tissue to improve in vivo detection of epithelial malignancies is compared to a non-superficial probe regarding depth response function and signal-to-noise ratio. Depth response measurements were performed in a phantom tissue model consisting of a polyethylene terephthalate disc in an 20%-Intralipid(®) solution. Sampling ranges of 0-200 and 0-300 μm were obtained for the superficial and non-superficial probe, respectively. The mean signal-to-noise ratio of the superficial probe increased by a factor of 2 compared with the non-superficial probe. This newly developed superficial Raman probe is expected to improve epithelial cancer detection in vivo.

The risk profiles of three clinical types of carcinoma in situ of the bladder

Study Type – Therapy (individual cohort)

Uroflowmetry in healthy women: a systematic review

Although uroflowmetry is a widely used diagnostic test, reference values of uroflowmetry parameters in women are lacking making it difficult to interpret the test results.

Is testosterone important in LUT function in men and women? ICI-RS 2015: Testosterone and the Lower Urinary Tract

This review article is a collaborative report based upon the Authors’ presentations and Group discussion on the role of testosterone (T) in the male and female lower urinary tract (LUT) which took place at the 6th International Consultation on Incontinence Research Societys (ICI‐RS) annual meeting, in Bristol, UK (September 8–10, 2015).

Pattern of recurrence after partial and total nephrectomy in non-metastatic renal cell carcinoma (RCC) of low, intermediate and high risk: Implications for follow-up.

601 Background: Guidelines recommend risk-adapted follow-up (FUP) after (partial) nephrectomy in non-metastatic RCC. VEGF-targeted therapy does not cure multiple metastatic RCC. FUP should therefore focus on local recurrences or single-/-oligometastases that may potentially be cured by local therapy. The rate of potentially curable recurrences per risk group is unknown and their pattern and management were analyzed in this study. Methods: From an IRB approved database non-metastatic RCC patients who underwent (partial) nephrectomy from 2004 to 2011 with a minimum FUP of ≥4 years and regular cross-sectional imaging were identified. Risk stratification was assigned to Leibovich- (clear-cell ) or UICC-stage- (non-clear cell) risk groups . Local recurrence, solitary and oligometastases defined as < 3 lesions at a single site were considered potentially curable by local therapy modalities. Recurrences were recorded as was the time to detection of recurrence (TDR) and their management. Results: From 230 patient...

18 Variabiliteit van de bulbaire arterie: een anatomische dissectie studie

SamenvattingTijdens een bulbaire urethrareconstructie wordt een zeer variabel verloop van de bulbaire arteriën gezien.

19 Seksuele functie bij jongvolwassen mannen na hypospadiecorrectie; evaluatie aan de hand van de Golombok Rust Inventory of Sexual Satisfaction

SamenvattingHet doel van hypospadiecorrecties is een voorwaarts gerichte urinestraal, een rechte erectie en een normaal cosmetisch uiterlijk te bewerkstelligen.